- Report
- October 2025
- 181 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- October 2025
- 195 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- October 2025
- 198 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 182 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- October 2025
- 364 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 367 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 497 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 174 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 274 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 192 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 473 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 378 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 271 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 402 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 510 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 504 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- June 2025
- 147 Pages
Global
From €4362EUR$4,900USD£3,811GBP
- Report
- September 2025
- 250 Pages
Global
From €3997EUR$4,490USD£3,493GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,493GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,493GBP

Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures.
The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy.
Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more